Stay with the evidence: On the ban on Fixed Dose Combination drugs

📌 Summary:

• The Health Ministry banned 16 Fixed Dose Combination (FDC) drugs as lacking therapeutic justification and "deemed irrational or unsafe" — covering dermatological drugs, analgesics & antispasmodics, and antibiotic-based formulations
• What an FDC is: a drug with two or more active pharmacological ingredients in a fixed ratio in a single dose; meant to improve compliance in chronic conditions (e.g., tuberculosis) by reducing pill burden
• Why irrational FDCs harm: patients may need different dose titrations (impossible with fixed ratios); allergic reactions cannot be traced to a specific ingredient; not all patients need every drug in the combination, exposing them to unnecessary side effects
• Antibiotic angle: irrational antibiotic FDCs drive and exacerbate antimicrobial resistance (AMR); in the 2016 action, 19% of the 330 banned FDCs were antibiotics
• Precedent: in March 2016 the government banned 330+ FDCs as irrational with immediate effect; such bans follow a detailed scientific review
• Implementation gap & solution: enforcement is the weak link — banned drugs were still sold because the message had not percolated down; the government must activate its monitoring and supervision arm to ensure last-mile compliance; State Drug Controllers, regulators, manufacturers and pharmacies are directed to stop stocking and selling the banned FDCs

🎯 UPSC Relevance: GS2 Governance — drug regulation, evidence-based policymaking and public health; AMR links to GS3 S&T

📝 Prelims Facts:

• 16 FDCs banned (2026); 330+ FDCs banned in March 2016 (19% antibiotics)
• FDC = two or more active ingredients in a fixed ratio in a single dose

🔑 Key Term: Fixed Dose Combination (FDC) — a formulation combining two or more active drugs in a fixed ratio in one dosage form